Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and membrane-associated lipid radicals are highly reactive chemical entities generated as byproducts of normal aerobic metabolism or in response to environmental stressors. ROS, such as superoxide and hydroxyl radicals, can initiate lipid peroxidation, a process where lipid radicals attack polyunsaturated fatty acids within cell membranes, leading to structural damage and the formation of toxic secondary products like malondialdehyde (Halliwell & Gutteridge, 2015). Vitamin E, primarily in the form of alpha-tocopherol, is the major fat-soluble antioxidant that resides within these lipid bilayers to intercept and neutralize lipid peroxyl radicals, thereby terminating the oxidative chain reaction and preserving membrane integrity (PubChem, 2024). This protective mechanism is essential for preventing cellular dysfunction associated with chronic conditions such as atherosclerosis, neurodegeneration, and cancer (NIH ODS, 2023). While Vitamin E is a critical physiological antioxidant, its use as a therapeutic agent to target ROS has yielded complex results in clinical trials, suggesting that the balance of oxidative signaling is highly regulated and context-dependent (Miller et al., 2005).
Vitamin E (alpha-tocopherol) acts as a chain-breaking antioxidant by donating a phenolic hydrogen atom to lipid peroxyl radicals (LOO•), converting them into less reactive lipid hydroperoxides and preventing the self-propagating chain reaction of lipid peroxidation in cellular membranes (Traber & Stevens, 2011; NIH ODS, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid radicals (ROS).